Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
927.15
-19.95 (-2.11%) Zydus Lifesciences informs about press release
Date: 07-11-2022Zydus Lifesciences has informed that it enclosed a copy of press release dated November 7, 2022, titled ‘Zydus receives EIR with Voluntary Action Indicated (VAI) from USFDA for its Moraiya manufacturing facility’.
The above information is a part of company’s filings submitted to BSE.